Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy.

Soa Fy AndriamandimbyMarie-Marie OliveYusuke ShimakawaFanjasoa RakotomananaIony Manitra RazanajatovoTsarasoa Malala AndrianinarivomananaJean-Pierre RavaloherySeta AndriamamonjyChristophe RogierJean-Michel Héraud

Published in: BMC public health (2017)

Madagascar has a high-intermediate level of endemicity for HBV infection with a severely limited capacity for its diagnosis and treatment. Higher HBsAg prevalence in rural or underprivileged populations underlines the importance of a public health approach to decentralize the management of chronic HBV carriers in Madagascar by using simple and low-cost diagnostic tools.

Keyphrases

hepatitis b virus
low cost
public health
risk factors
liver failure
south africa